Isis backs GlaxoSmithKline on directors' pay

Isis Asset Management, the £63.5bn (€94.8bn) UK fund manager, will vote in favour of GlaxoSmithKline's executive pay policy at the pharmaceutical group's annual meeting next week.

The decision by Isis, which has taken a tough stance on generous director pay packages, comes as a significant boost for GlaxoSmithKline, which last year became the first UK company to see its remuneration policy voted down by shareholders.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire